Managing Cost and Access for Long-Term GLP-1 Therapy One of the most significant barriers to long-term GLP-1 use has been cost, particularly for patients without insurance coverage
The 12 mg dose outperforms 4 mg and 8 mg in every trial
For employers operating on tight benefit budgets, thats an untenable increase to absorb especially when utilization consistently came in higher than projected. In conversations documented by the Kaiser Family Foundation and Peterson Center on Healthcare, employers described trying multiple cost-management strategies step therapy requirements, prior authorization, weight-loss program prerequisites before ultimately concluding that no guardrail was controlling the spend fast enough. Importantly, the law doesnt require employers to offer GLP-1 coverage
Be honest with your doctor: Drinking habits affect dose and results
[DOI] [PubMed] [Google Scholar] 28.Baig K, Dusetzina SB, Kim DD, Leech AA
This study investigated the effects of a diet and exercise program compared to an attention control (where participants are provided with information about nutrition and physical activity)